MedPath

Bausch & Lomb Americas Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

FDA:13

Drug Approvals

loteprednol etabonate

Approval Date
Feb 9, 2024
FDA

Timolol Maleate

Approval Date
Jan 18, 2024
FDA

Loteprednol Etabonate

Approval Date
Jun 30, 2023
FDA

Loteprednol Etabonate

Approval Date
Apr 7, 2023
FDA

Phenylephrine Hydrochloride

Approval Date
Mar 31, 2023
FDA

Fluorescein Sodium and Benoxinate Hydrochloride

Approval Date
Mar 16, 2023
FDA

bromfenac ophthalmic solution

Approval Date
Jan 31, 2023
FDA

Bepotastine Besilate

Approval Date
Aug 31, 2022
FDA

Tetracaine Hydrochloride

Approval Date
May 1, 2022
FDA

Timolol Maleate

Approval Date
Apr 30, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.